SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028331
Filing Date
2016-11-08
Accepted
2016-11-08 16:11:31
Documents
51
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-10q_20160930.htm 10-Q 2647252
2 EX-10.26 XXIX fgen-ex1026_175.htm EX-10.26 22518
3 EX-10.26 XXX fgen-ex1026_174.htm EX-10.26 21444
4 EX-31.1 fgen-ex311_8.htm EX-31.1 8294
5 EX-31.2 fgen-ex312_6.htm EX-31.2 8288
6 EX-32.1 fgen-ex321_10.htm EX-32.1 7567
  Complete submission text file 0001564590-16-028331.txt   7270656

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fgen-20160930.xml EX-101.INS 1620260
8 XBRL TAXONOMY EXTENSION SCHEMA fgen-20160930.xsd EX-101.SCH 34928
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20160930_cal.xml EX-101.CAL 49399
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20160930_def.xml EX-101.DEF 112490
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20160930_lab.xml EX-101.LAB 270518
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20160930_pre.xml EX-101.PRE 217838
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 161981401
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences